Today Dr. Shanti Farrington, Principal Academic in Psychology, presented our research work on dementia in India today. She was invited to speak to the ‘Research Participation Group of the Ageing & Dementia Research Centre (ADRC) at Bournemouth University. She addressed a range of interesting issues, for example she spoke about lack of training of health care workers in dealing with people living with dementia, but also in lack of experience in diagnosing different forms of dementia. She also spoke about the lack of experts neurologists in India, and the ageing population in this vast country.
The discussion with the online audience also covered the role of diet in prevention of dementia and the limitations of using online health promotion material and general information on dementia in English, where some many languages are spoken. The underpinning research was largely funded by GCRF (Global Challenges Research Fund).
Prof. Edwin van Teijlingen
CMWH (Centre for Midwifery & Women’s Health)
Free training sessions for dementia researchers
Two little mishaps in a row
BU Dementia paper published today
New Nepalese migrant health paper published










SPROUT Returns: Designing Sustainability in Research Practice – Wednesday 20 May 12-2pm
Innovative Approaches to Doctoral Supervision: Selected Case Studies
3C Event: Research Culture, Community & Canapés-Tuesday 19 May 1-2pm
New chapters published in maternity book on risk
The British Academy European Research Council Grant Support Sessions
Grant Writing Workshops: Master the Art of the Winning Proposal
Apply now to take part in the 2026 ESRC Festival of Social Science
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease